Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study by Awada, Ahmad, Dr Prof, Garcia, Agustin A, MD, Chan, Stephen, MD, Jerusalem, Guy H M, Prof, Coleman, Robert E, Prof, Huizing, Manon T, Prof, Mehdi, Aminder, MD, O'Reilly, Sue M, MD, Hamm, John T, MD, Barrett-Lee, Peter J, Prof, Cocquyt, Veronique, Prof, Sideras, Kostandinos, MD, Young, David E, MD, Zhao, Carol, MS, Chia, Yen Lin, PhD, Hoch, Ute, PhD, Hannah, Alison L, MD, Perez, Edith A, Prof

Get full text